Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease

OBJECTIVES: Inflammatory bowel diseases (IBD), comprised of Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by a complex pathophysiology that is thought to result from an aberrant immune response to a dysbiotic luminal microbiota in genetically susceptible individuals. New techno...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Transl Gastroenterol
Autors principals: Moustafa, Ahmed, Li, Weizhong, Anderson, Ericka L, Wong, Emily H M, Dulai, Parambir S, Sandborn, William J, Biggs, William, Yooseph, Shibu, Jones, Marcus B, Venter, J Craig, Nelson, Karen E, Chang, John T, Telenti, Amalio, Boland, Brigid S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2018
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5795019/
https://ncbi.nlm.nih.gov/pubmed/29345635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ctg.2017.58
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars